TSRL Receives Second-Year NIH Notice of Award to Advance Microneedle Patch for Overactive Bladder Therapy

TSRL, Inc. today announced that it has received its second-year Notice of Award from the National Institutes of Health (NIH) to continue advancing its microneedle patch for the treatment of overactive bladder. The award, issued last month, provides nearly $1.1 million in continued support under Grant Number 5R44DK143799-03.